Evidence Hub

Remission of severe familial proteinuria in a Bracco Italiano dog

Inman AL, Allen-Durrance AE

The Canadian veterinary journal = La revue veterinaire canadienne, 2026

Abstract

The objective of this report was to document clinical remission of suspected familial proteinuria in a Bracco Italiano dog. A 4-year-old intact female Bracco Italiano with a familial history of amyloidosis was presented because of unilateral chemosis, polyuria, and polydipsia. Hypoalbuminemia and severe proteinuria were detected via initial diagnostics. Although no renal histopathologic assessment was done, there was a strong clinical suspicion for renal amyloidosis. The dog was treated with telmisartan and colchicine (in addition to other therapies) for proteinuria and achieved clinical remission > 5 y post-diagnosis. Key clinical message: Telmisartan is an appropriate 1st-line therapy for proteinuric dogs. Favorable long-term outcomes are possible for dogs with severe proteinuria. Prospective studies are warranted to evaluate effects of telmisartan on AA amyloidogenesis.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free